Sculptor Capital’s Precigen PGEN Stock Holding History

Sculptor Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-77,258	Closed	-$788K	–	762
2020 Q4	$788K	Hold	77,258	–	–	﹤0.01%	370
2020 Q3	$270K	Hold	77,258	–	–	﹤0.01%	306
2020 Q2	$386K	Hold	77,258	–	–	﹤0.01%	224
2020 Q1	$263K	Sell	77,258 -39,000	-34%	-$168K	﹤0.01%	192
2019 Q4	$637K	Hold	116,258	–	–	0.01%	226
2019 Q3	$665K	Buy	116,258 +77,000	+196%	+$523K	0.01%	249
2019 Q2	$301K	Sell	39,258 -38,000	-49%	-$205K	﹤0.01%	252
2019 Q1	$406K	Buy	77,258 +49,358	+177%	+$342K	﹤0.01%	190
2018 Q4	$182K	Hold	27,900	–	–	﹤0.01%	217
2018 Q3	$480K	Sell	27,900 -272,600	-91%	-$4.05M	﹤0.01%	215
2018 Q2	$4.19M	Buy	+300,500	New	+$5.08M	0.02%	118
2017 Q4	–	Sell	-122,000	Closed	-$2.32M	–	128
2017 Q3	$2.32M	Hold	122,000	–	–	0.01%	212
2017 Q2	$2.94M	Hold	122,000	–	–	0.02%	207
2017 Q1	$2.42M	Buy	+122,000	New	+$2.72M	0.01%	205
2016 Q3	–	Sell	-47,221	Closed	-$1.15M	–	367
2016 Q2	$1.15M	Hold	47,221	–	–	0.01%	278
2016 Q1	$1.59M	Buy	+47,221	New	+$1.49M	0.01%	290

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sculptor Capital's PGEN Position: Q1 2021 in Review

Sculptor Capital sold out of Precigen (PGEN) in Q1 2021, closing a stake of 77,258 shares — an estimated $788K sold.

Sculptor Capital first reported a position in PGEN in Q1 2016 and held it in 16 quarters. The position peaked at $4.19M in Q2 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2021.

Sculptor Capital reported no remaining Precigen position as of Q1 2021 after selling out during the quarter.
Sculptor Capital sold 77,258 Precigen shares in Q1 2021, an estimated $788K.
Sculptor Capital first reported a position in Precigen in Q1 2016 and held it in 16 quarters.
Sculptor Capital's Precigen position peaked at $4.19M in Q2 2018.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2021.

Based on Sculptor Capital's 13F filing for Q1 2021, filed 14 May 2021.